SUZETTE CONTRERAS: Open Payments
NPI 1790367951 · WINFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 20 payments from 10 companies in 2025. Trend: 2023 $939 · 2024 $1,129 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $156 |
| AstraZeneca Pharmaceuticals LP | 5 | $142 |
| Otsuka America Pharmaceutical, Inc. | 4 | $92 |
| Vifor Pharma, Inc. | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Ardelyx, Inc. | 1 | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $20 |
| SCPHARMACEUTICALS INC. | 1 | $19 |
| Calliditas Therapeutics US Inc. | 1 | $17 |
| Travere Therapeutics, Inc. | 1 | $13 |
Products named: JARDIANCE, FARXIGA, JYNARQUE, Veltassa, VOYXACT, Fabhalta, IBSRELA, LifeVest.
Industry payments across IL — which companies pay providers there.
